DH endorses batch recall of Human Albumin 20% "Biotest" Infusion (with photo)

     ‚ÄčThe Department of Health (DH) today (April 27) endorsed a licensed drug wholesaler, Chong Lap (HK) Co Ltd, to recall 19 batches of Human Albumin 20% "Biotest" Infusion (Registration No. HK-16685) from the market for a potential quality issue.

     The affected batches are: B225065, B225105, B225135, B225654, B234026, B234046, B234306, B234514, B234645, B234784, B234866, B235174, B235364, B235525, B235684, B234926, B225056, B235066 and B235256.

     The DH received notification from Chong Lap that the pharmaceutical product's manufacturer in Germany was recalling the above batches as they might have been contaminated with the cooling liquid circulating in the production equipment during manufacture. According to the risk assessment conducted by the manufacturer, the potential risk to patients using the product is low and the recall is a precautionary measure. The DH's investigation is continuing.

     The above product, containing human albumin, is a prescription medicine used for the treatment of low plasma volume and hypoalbuminaemia (abnormally low blood albumin). According to Chong Lap, about 64 000 bottles of the affected batches have been supplied to private hospitals, private doctors and local pharmacies. The DH will closely monitor the recall.

     "So far, the DH has not received any adverse reaction reports in connection with the product," a spokesman for the DH said.

     Chong Lap has set up a hotline (2736 3078) to answer related enquiries.

     "Members of the public should consult healthcare professionals if in doubt or feeling unwell after using the product," the spokesman added.

Ends/Thursday, April 27, 2017
Issued at HKT 18:37